Nathan Cantoni
Overview
Explore the profile of Nathan Cantoni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
284
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Ruefer A, Bapst C, Benz R, Bremerich J, Cantoni N, Infanti L, et al.
Swiss Med Wkly
. 2017 Nov;
147:w14550.
PMID: 29120023
Hyperferritinaemia is a frequent clinical problem. Elevated serum ferritin levels can be detected in different genetic and acquired diseases and can occur with or without anaemia. It is therefore important...
22.
Bonadies N, Feller A, Rovo A, Ruefer A, Blum S, Gerber B, et al.
Cancer Epidemiol
. 2017 Jan;
46:85-92.
PMID: 28056392
Myelodysplastic syndromes (MDS) are emerging disorders of the elderly with an increasing burden on healthcare systems. He we report on the first population-based, epidemiological analysis of patients diagnosed with MDS...
23.
Mey U, Brugger W, Schwarb H, Pederiva S, Schwarzer A, Dechow T, et al.
Br J Haematol
. 2016 Dec;
176(5):770-782.
PMID: 27983764
The combination of lenalidomide (Revlimid , R) and dexamethasone (d) is a standard regimen for patients with relapsed/refractory multiple myeloma (rrMM). With this regimen, only a small fraction of patients...
24.
Cantoni N, Recher M
Ther Umsch
. 2014 Jan;
71(1):31-43.
PMID: 24394207
Primary Immunodeficiencies (PID) are rare, genetically determined diseases that cause dysfunctional immunity, clinically presenting as susceptibility to infection but also as autoimmunity due to deficient immune tolerance. More than 180...
25.
Mendez A, Bargetzi M, Huber A, Cantoni N
Ther Umsch
. 2013 Jul;
70(8):449-55.
PMID: 23876751
In the last few decades we have seen a significant decrease in the rates of analytical errors in clinical laboratories. The test performances have improved, new parameters have been introduced,...
26.
Janthur W, Cantoni N, Mamot C
Int J Mol Sci
. 2013 Feb;
13(12):16020-45.
PMID: 23443108
Drug conjugates have been studied extensively in preclinical in vitro and in vivo models but to date only a few compounds have progressed to the clinical setting. This situation is...
27.
Nann-Rutti S, Tzankov A, Cantoni N, Halter J, Heim D, Tsakiris D, et al.
Biol Blood Marrow Transplant
. 2012 Jul;
18(11):1765-70.
PMID: 22796340
Expansions of CD3+ large granular lymphocytes (LGLs) after allogeneic hematopoietic stem cell transplantation (HSCT) have been described. We sought to evaluate incidence, characteristics, and clinical significance of persistent T cell...
28.
Cantoni N, Heizmann M, Bargetzi M
Br J Haematol
. 2012 Feb;
157(5):639-41.
PMID: 22329466
No abstract available.
29.
Cantoni N, Hirsch H, Khanna N, Gerull S, Buser A, Bucher C, et al.
Biol Blood Marrow Transplant
. 2010 Apr;
16(9):1309-14.
PMID: 20353832
Cytomegalovirus (CMV) infection and graft-versus-host disease (GVHD) are important complications after allogeneic hematopoietic stem cell transplantation (HSCT) with a clear link. Multiple studies show that GVHD and its treatment put...
30.
Cantoni N, Meyer P, Katan M, Kappos L, Hess C, Daikeler T
Rheumatol Int
. 2009 Sep;
30(12):1681-3.
PMID: 19774381
No abstract available.